Cerebrovascular reactivity (CVR) shows promise as a biomarker of vascular integrity and may benefit from a repeatable, reliable, and microvasculature-sensitive acquisition. A combined spin- and gradient-echo (SAGE) functional MRI (fMRI) acquisition may improve repeatability and reliability compared to single spin- (SE) and gradient-echo (GRE) fMRI and provide a microvascular-weighted analysis. The most repeatable and reliable MRI acquisition CVR maps were compared across three CVR paradigms: a breath-hold task, a breath modulation task, and a resting state acquisition. SAGE-fMRI data was acquired in fifteen young adults at two timepoints. Mean gray matter (GM) within-subject coefficient of variation (wCV) and intraclass correlation coefficient (ICC) were compared within the quantitative and weighted SAGE-fMRI CVR maps and single GRE- and SE-fMRI CVR. Total and microvascular MRI inputs with lowest wCV and highest ICC were used to compare three CVR paradigms. Total and microvascular weighted SAGE-fMRI CVR had the lowest wCV and highest ICC across paradigms. The breath-hold paradigm produced significantly higher GM CVR estimates. SAGE repeatably and reliably measures CVR and offers a simultaneous, complementary analysis on total and microvascular scales. The breath-hold paradigm showed significantly higher CVR estimates, but less compliance-dependent protocols may be ideal for applications in patient populations.
YezhuvathUSUhJChengY, et al.
Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer’s disease. Neurobiol Aging2012;
33: 75–82.
2.
Glass UmfleetLPommyJCohenAD, et al.
Decreased cerebrovascular reactivity in mild cognitive impairment phenotypes. J Alzheimers Dis2023;
94: 1503–1513.
3.
LiuPLinZHazelK, et al.
Cerebrovascular reactivity (CVR) MRI as a biomarker for small vessel disease (SVD) related cognitive decline: multi-site validation in the MarkVCID consortium. Alzheimers Dement2024;
20: 5281–5289.
4.
RichiardiJMonschAUHaasT, et al.
Altered cerebrovascular reactivity velocity in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging2015;
36: 33–41.
5.
SurSLinZLiY, et al.
Association of cerebrovascular reactivity and Alzheimer pathologic markers with cognitive performance. Neurology2020;
95: e962–e972.
6.
SleightEStringerMSClancyU, et al.
Cerebrovascular reactivity in patients with small vessel disease: a cross-sectional study. Stroke2023;
54: 2776–2784.
7.
LeeBCTsaiHHHuangAPH, et al.
Arterial spin labeling imaging assessment of cerebrovascular reactivity in hypertensive small vessel disease. Front Neurol2021;
12: 640069–8.
8.
SuriSMackayCEKellyME, et al.
Reduced cerebrovascular reactivity in young adults carrying the APOE ε4 allele. Alzheimers Dement2015;
11: 648–657.e1.
9.
KimDHughesTMLipfordME, et al.
Relationship between cerebrovascular reactivity and cognition among people with risk of cognitive decline. Front Physiol2021;
12: 645342.
10.
LiuPDe VisJBLuH.Cerebrovascular reactivity (CVR) MRI with CO2 challenge: a technical review. Neuroimage2019;
187: 104–115.
11.
PintoJBrightMGBulteDP, et al.
Cerebrovascular reactivity mapping without gas challenges: a methodological guide. Front Physiol2020;
11: 608475.
12.
SpanoVRMandellDMPoublancJ, et al.
CO2 blood oxygen level-dependent MR mapping of cerebrovascular reserve in a clinical population: safety, tolerability, and technical feasibility. Radiology2013;
266: 592–598.
13.
BrightMGBulteDPJezzardP, et al.
Characterization of regional heterogeneity in cerebrovascular reactivity dynamics using novel hypocapnia task and BOLD fMRI. Neuroimage2009;
48: 166–175.
JahanianHChristenTMoseleyME, et al.
Measuring vascular reactivity with resting-state blood oxygenation level-dependent (BOLD) signal fluctuations: a potential alternative to the breath-holding challenge?J Cereb Blood Flow Metab2017;
37: 2526–2538.
16.
LiuPXuCLinZ, et al.
Cerebrovascular reactivity mapping using intermittent breath modulation. Neuroimage2020;
215: 116787.
17.
LiuPLiYPinhoM, et al.
Cerebrovascular reactivity mapping without gas challenges. Neuroimage2017;
146: 320–326.
18.
GolestaniAMWeiLLChenJJ.Quantitative mapping of cerebrovascular reactivity using resting-state BOLD fMRI: validation in healthy adults. Neuroimage2016;
138: 147–163.
19.
SticklandRCZvolanekKMMoiaS, et al.
A practical modification to a resting state fMRI protocol for improved characterization of cerebrovascular function. Neuroimage2021;
239: 118306.
20.
GatiJSMenonRSUgurbilK, et al.
Experimental determination of the BOLD field strength dependence in vessels and tissue. Magn Reson Med1997;
38: 296–302.
21.
PosseSWieseSGembrisD, et al.
Enhancement of BOLD-contrast sensitivity by single-shot multi-echo functional MR imaging. Magn Reson Med1999;
42: 87–97.
22.
PoserBAVersluisMJHoogduinJM, et al.
BOLD contrast sensitivity enhancement and artifact reduction with multiecho EPI: parallel-acquired inhomogeneity-desensitized fMRI. Magn Reson Med2006;
55: 1227–1235.
23.
CohenADJagraASYangB, et al.
Detecting task functional MRI activation using the multiband multiecho (MBME) echo-planar imaging (EPI) sequence. J Magn Reson Imaging2021;
53: 1366–1374.
24.
EvansJWKunduPHorovitzSG, et al.
Separating slow BOLD from non-BOLD baseline drifts using multi-echo fMRI. Neuroimage2015;
105: 189–197.
25.
KunduPInatiSJEvansJW, et al.
Differentiating BOLD and non-BOLD signals in fMRI time series using multi-echo EPI. Neuroimage2012;
60: 1759–1770.
26.
CohenADJagraASVisserNJ, et al.
Improving the breath-holding CVR measurement using the multiband multi-echo EPI sequence. Front Physiol2021;
12: 619714.
27.
MoiaSTermenonMUruñuelaE, et al.
ICA-based denoising strategies in breath-hold induced cerebrovascular reactivity mapping with multi echo BOLD fMRI. Neuroimage2021;
233: 117914.
28.
RosenbergGA.Blood-brain barrier permeability in aging and Alzheimer’s disease. J Prev Alzheimers Dis2014;
1: 138–139.
29.
SweeneyMDMontagneASagareAP, et al.
Vascular dysfunction – the disregarded partner of Alzheimer’s disease. Alzheimer’sDement2019;
15: 158.
30.
MarkusHSErik de LeeuwF.Cerebral small vessel disease: recent advances and future directions. Int J Stroke2023;
18: 4–14.
31.
SchmiedeskampHStrakaMNewbouldRD, et al.
Combined spin- and gradient-echo perfusion-weighted imaging. Magn Reson Med2012;
68: 30–40.
32.
StokesAMSkinnerJTQuarlesCC.Assessment of a combined spin-and gradient-echo (SAGE) DSC-MRI method for preclinical neuroimaging. Magn Reson Imaging2014;
32: 1181–1190.
33.
KeelingEGBergaminoMRagunathanS, et al.
Optimization and validation of multi-echo, multi-contrast SAGE acquisition in fMRI. Imaging Neurosci (Camb)2024;
2: 1–20.
34.
BoxermanJLHambergLMRosenBR, et al.
MR contrast due to intravascular magnetic susceptibility perturbations. Magn Reson Med1995;
34: 555–566.
35.
FaulFErdfelderELangA-G, et al.
A, et al. G * power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods2007;
39: 175–191.
36.
LippIMurphyKCaserasX, et al.
Agreement and repeatability of vascular reactivity estimates based on a breath-hold task and a resting state scan. Neuroimage2015;
113: 387–396.
37.
CoxRW.AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res1996;
29: 162–173.
38.
JenkinsonMBeckmannCBehrensT, et al.
FSL. Neuroimage2012;
62: 782–790.
39.
BhogalA. abhogal-lab/seeVR.
40.
BhogalA.Medullary vein architecture modulates the white matter BOLD cerebrovascular reactivity signal response to CO2: observations from high-resolution T2 * weighted imaging at 7T. Neuroimage2021;
245: 118771.
41.
SchmiedeskampHStrakaMBammerR.Compensation of slice profile mismatch in combined spin- and gradient-echo EPI pulse sequences. Magn Reson Med2012;
67: 378.
42.
KeelingEGSiscoNJMcElvogueMM, et al.
Rapid simultaneous estimation of relaxation rates using multi-echo, multi-contrast MRI. Magn Reson Imaging2024;
112: 116–127.
43.
LindquistMAGeuterSWagerTD, et al.
Modular preprocessing pipelines can reintroduce artifacts into fMRI data. Hum Brain Mapp2019;
40: 2358–2376.
44.
MoiaSSticklandRCAyyagariA, et al.
Voxelwise optimization of hemodynamic lags to improve regional CVR estimates in breath-hold fMRI. Proc Annu Int Conf IEEE Eng Med Biol Soc EMBS2020;
2020: 1489–1492.
45.
ZvolanekKMMoiaSDeanJN, et al.
Comparing end-tidal CO2, respiration volume per time (RVT), and average gray matter signal for mapping cerebrovascular reactivity amplitude and delay with breath-hold task BOLD fMRI. Neuroimage2023;
272: 120038.
AltmanDGBlandJM.Measurement in medicine: the analysis of method comparison studies. Stat1983;
32: 307.
51.
BlandMJAltmanDG.Statistical methods for assessing agreement between two methods of clinical measurement. Lancet1986;
327: 307–310.
52.
KassambaraA.rstatix: Pipe-Friendly Framework for Basic Statistical Tests. R package version 0.7.2. 2023. https://rpkgs.datanovia.com/rstatix/.
53.
HuckJWannerYFanAP, et al.
High resolution atlas of the venous brain vasculature from 7 T quantitative susceptibility maps. Brain Struct Funct2019;
224: 2467–2485.
54.
YeoBTTKrienenFMSepulcreJ, et al.
The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol2011;
106: 1125–1165.
55.
ThomasBPLiuPParkDC, et al.
Cerebrovascular reactivity in the brain white matter: magnitude, temporal characteristics, and age effects. J Cereb Blood Flow Metab2014;
34: 242–247.
56.
RostrupELawIBlinkenbergM, et al.
Regional differences in the CBF and BOLD responses to hypercapnia: a combined PET and fMRI study. Neuroimage2000;
11: 87–97.
57.
PreibischCHaaseA.Perfusion imaging using spin-labeling methods: contrast-to-noise comparison in functional MRI applications. Magn Reson Med2001;
46: 172–182.
58.
HeleniusJPerkiöJSoinneL, et al.
Cerebral hemodynamics in a healthy population measured by dynamic susceptibility contrast MR imaging. Acta Radiol2003;
44: 538–546.
59.
KimSGOgawaS.Biophysical and physiological origins of blood oxygenation level-dependent fMRI signals. J Cereb Blood Flow Metab2012;
32: 1188–1206.
60.
DuvernoyHMDelonSVannsonJL.Cortical blood vessels of the human brain. Brain Res Bull1981;
7: 519–579.
61.
BeaulieuC.The basis of anisotropic water diffusion in the nervous system – a technical review. NMR Biomed2002;
15: 435–455.
62.
SchellekensWBhogalAARoefsECA, et al.
The many layers of BOLD. The effect of hypercapnic and hyperoxic stimuli on macro- and micro-vascular compartments quantified by CVR, M, and CBV across cortical depth. J Cereb Blood Flow Metab2023;
43: 419–432.
63.
ParkesLMSchwarzbachJVBoutsAA, et al.
Quantifying the spatial resolution of the gradient echo and spin echo BOLD response at 3 tesla. Magn Reson Med2005;
54: 1465–1472.
64.
ConijnMMAHoogduinJMvan der GraafY, et al.
Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity – a 7T study. Neuroimage2012;
59: 950–956.
65.
Iturria-MedinaYSoteroRCToussaintPJ, et al.
Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis. Nat Commun2016;
7: 11934.
66.
Sierra-MarcosA.Regional cerebral blood flow in mild cognitive impairment and Alzheimer’s disease measured with arterial spin labeling magnetic resonance imaging. Int J Alzheimers Dis2017;
2017: 5479597.
67.
KlunkWEEnglerHNordbergA, et al.
Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol2004;
55: 306–319.
68.
BucknerRLSnyderAZShannonBJ, et al.
Molecular, structural, and functional characterization of Alzheimer’s disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci2005;
25: 7709–7717.
69.
BucknerRLSepulcreJTalukdarT, et al.
Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer’s disease. J Neurosci2009;
29: 1860–1873.
70.
RagotDMChenJJ.Characterizing contrast origins and noise contribution in spin-echo EPI BOLD at 3 T. Magn Reson Imaging2019;
57: 328–336.
71.
LeeS-PSilvaACUgurbilK, et al.
Diffusion-weighted spin-echo fMRI at 9.4 T: microvascular/tissue contribution to BOLD signal changes. Magn Reson Med1999;
42: 919–928.
72.
DuongTQYacoubEAdrianyG, et al.
Microvascular BOLD contribution at 4 and 7 T in the human brain: gradient-echo and spin-echo fMRI with suppression of blood effects. Magn Reson Med2003;
49: 1019–1027.
73.
LindquistMA.The statistical analysis of fMRI data. Stat Sci2008;
23: 439–464.
74.
JinNGuoYZhangZ, et al.
GESFIDE-PROPELLER approach for simultaneous R2 and R2* measurements in the abdomen. Magn Reson Imaging2013;
31: 1760–1765.
75.
NiWWChristenTZaharchukG.Benchmarking transverse spin relaxation based oxygenation measurements in the brain during hypercapnia and hypoxia. J Magn Reson Imaging2017;
46: 704–714.
76.
ShahNJda SilvaNAYunSD.Perfusion weighted imaging using combined gradient/spin echo EPIK: Brain tumour applications in hybrid MR‐PET. Hum Brain Mapp2021;
42: 4144–4154.
77.
KüppersFYunSDShahNJ.Development of a novel 10-echo multi-contrast sequence based on EPIK to deliver simultaneous quantification of T2 and T2* with application to oxygen extraction fraction. Magn Reson Med2022;
88: 1608–1623.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
